Mawson Infrastructure Group Inc. — Director's Dealing 2018

May 1, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Wize Pharma, Inc. (WIZP)
CIK: 0001218683
Period of Report: 2018-04-04

Reporting Person: Eisenberg Or (Acting CEO, CFO, Treas & Secy.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-04-04	Restricted Stock Units (RSU)	A	40100	—	Acquired	40100	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-04-04	Stock Option (right to buy)	$3.59	A	36000	Acquired	2025-04-04	Common Stock (36000)	Direct

Footnotes

F1: The RSUs were fully vested upon grant.

F2: The RSUs were granted as compensation for services as the CEO of the Issuer.

F3: The Stock Option is exercisable in twelve equal installments over the three year period from the date of grant.

F4: The Stock Option was granted as compensation for services as the CEO of the Issuer.